This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud to spotlight the groundbreaking work of its wholly owned research arm, DaVita…
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2025. “We’re reporting another solid quarter, fueled by our unwavering focus on patient care,” said…
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time. The company plans…
DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care…
DaVita Inc. (NYSE: DVA) (“DaVita”) announced today the upsize and pricing of its previously announced private offering (the “offering”) of its 6.750% senior notes due 2033 (the “2033 notes”). The…